They have evolved with changing industry dynamics, adopted new technology, and made prudent financial decisions
Fresh approvals to market new generic formulations in the US and plans for a wider global footprint mean the firm is in the pink of health
The last-mile linkage provider has lost the trust of investors after frequent changes in its business model
Industry watchers wonder if companies in this space are due for a bit of a pause
A list of companies that have built up robust businesses